CV Sciences (CVSI) Change in Receivables (2013 - 2026)
CV Sciences' (CVSI) quarterly Change in Receivables came in at -$22000.0 in Q1 2026, up 78.0% year-on-year from -$12359.6 in Q1 2025, and down 466.67% quarter-over-quarter from $6000.0 in Q4 2025.
CV Sciences (CVSI) Change in Receivables (2013 - 2026) Analysis & Trends
CV Sciences has disclosed Change in Receivables across 14 years of filings, most recently posting -$22000.0 for Q1 2026.
- Change in Receivables for Q1 2026 came in at -$22000.0, up 78.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$46000.0 (up 46.51% YoY), and the FY2025 annual result was -$124000.0, down 247.62% from the prior year.
- Change in Receivables came in at -$22000.0 for Q1 2026 at CV Sciences, down from $6000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $130000.0 in Q2 2024 to a low of -$1.1 million in Q1 2022.
- The 5-year median for Change in Receivables is -$22000.0 (2026), against an average of -$87000.0.
- Across the five-year window, Change in Receivables tumbled 724.06% in 2022 and soared 382.61% in 2024, its largest moves.
- CV Sciences' Change in Receivables stood at $107000.0 in 2022, then tumbled by 332.71% to -$249000.0 in 2023, then soared by 141.37% to $103000.0 in 2024, then plunged by 94.17% to $6000.0 in 2025, then plunged by 466.67% to -$22000.0 in 2026.
- The last three Change in Receivables figures came in at -$22000.0 (Q1 2026), $6000.0 (Q4 2025), and -$142000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -78.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 106.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -38.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 81.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 23.22 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 2.23 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 116.25 Mn |
| 10 | CV Sciences | - | - | 1.56 Mn | -22,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22,000.00 |
| Mar 31, 2026 | -22,000.00 |
| Dec 31, 2025 | 6,000.00 |
| Dec 31, 2025 | 6,000.00 |
| Sep 30, 2025 | -142,000.00 |
| Sep 30, 2025 | -142,000.00 |
| Jun 30, 2025 | 112,000.00 |
| Jun 30, 2025 | 112,000.00 |
| Mar 31, 2025 | -100,000.00 |
| Mar 31, 2025 | -100,000.00 |
| Dec 31, 2024 | 103,000.00 |
| Dec 31, 2024 | 103,000.00 |
| Sep 30, 2024 | -219,000.00 |
| Sep 30, 2024 | -219,000.00 |
| Jun 30, 2024 | 130,000.00 |
| Jun 30, 2024 | 130,000.00 |
| Mar 31, 2024 | 70,000.00 |
| Mar 31, 2024 | 70,000.00 |
| Dec 31, 2023 | -249,000.00 |
| Dec 31, 2023 | -249,000.00 |